The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer An Analysis Based on Individual Participant Data
暂无分享,去创建一个
H. Groen | M. Parmar | M. Tsuboi | G. Scagliotti | S. Burdett | R. Arriagada | J. Pignon | B. Dautzenberg | R. Stephens | Yi-long Wu | P. Bunn | J. V. van Meerbeeck | Xue-Ning Yang | R. Rosell | T. le Chevalier | D. Waller | A. Aupérin | C. Le Péchoux | J. Tierney | N. Navani | E. Vallières | A. Knuuttila | L. Rydzewska | V. Westeel | D. Gilligan | D. Fisher | L. Stewart | David H. Johnson | Sarah Burdett | Sarah Larysa H.M. Jayne F. Anne Thierry Cécile Jean-Pier Burdett Rydzewska Tierney Auperin Le Cheval | J. Roth
[1] M. Oudkerk,et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] Jérémie F. Cohen,et al. Added value of combined endobronchial and oesophageal endosonography for mediastinal nodal staging in lung cancer: a systematic review and meta-analysis. , 2016, The Lancet. Respiratory medicine.
[3] M. Wouters,et al. The Quality of Staging Non-Small Cell Lung Cancer in the Netherlands: Data From the Dutch Lung Surgery Audit. , 2016, The Annals of thoracic surgery.
[4] H. Groen,et al. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] D. Baldwin,et al. FDG-PET/CT imaging for mediastinal staging in patients with potentially resectable non-small cell lung cancer. , 2015, JAMA.
[6] M. Parmar,et al. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial , 2015, The Lancet. Respiratory medicine.
[7] L. Portney,et al. Foundations of Clinical Research: Applications to Practice , 2015 .
[8] Leslie G. Portney Dpt PhD Fapta,et al. Foundations of Clinical Research: Applications to Practice , 2015 .
[9] Sarah Burdett,et al. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data , 2014, The Lancet.
[10] D. de Ruysscher,et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] L. Tanoue,et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.
[12] C. Dooms,et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. , 2010, JAMA.
[13] H. Groen,et al. Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trial , 2010, Thorax.
[14] J. Crowley,et al. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Andrea Bezjak,et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.
[16] Keith M Godfrey,et al. Validation of a maternal questionnaire on correlates of physical activity in preschool children , 2009, The international journal of behavioral nutrition and physical activity.
[17] Nasser K. Altorki,et al. Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging. , 2009, The Journal of thoracic and cardiovascular surgery.
[18] Carlo Bartolozzi,et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). , 2008, The Lancet. Oncology.
[19] O. Dalesio,et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review , 2007, The Lancet.
[20] P. V. Van Schil,et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[21] R. Cerfolio,et al. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. , 2005, The Annals of thoracic surgery.
[22] Yi-long Wu,et al. P-645 A randomized trial comparing neoadjuvant gemicitabine plus carboplatin or cisplatin followed by surgery with surgery alone in Clinical Stage IIIA non-small-cell lung cancer (NSCLC) , 2005 .
[23] J. Rivas,et al. Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. , 2005, The Annals of thoracic surgery.
[24] Robert D Timmerman,et al. Stereotactic body radiation therapy. , 2004, Current problems in cancer.
[25] H. Kato,et al. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). , 2003, The Journal of thoracic and cardiovascular surgery.
[26] G. T. ten Velde,et al. Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] B. Nathwani,et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] E. Lemarié,et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Orit Shechtman,et al. Foundations of Clinical Research: Applications to Practice, 2nd Edition, Leslie Gross Portney, Mary P. Watkins. Prentice Hall, Upper Saddle River, NJ (2000), 752 pages. $60 , 2001 .
[30] E. Smit,et al. Randomized multicenter phase II study of chemotherapy followed by surgery versus surgery alone in stage I and II non-small cell lung cancer (NSCLC) , 2000 .
[31] J. Roth,et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. , 1994, Journal of the National Cancer Institute.
[32] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.